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ABSTRACT 
The CCR4-NOT complex has been shown to have mul- 
tiple roles in mRNA metabolism, including that of 
transcriptional elongation, mRNA transport, and nu- 
clear exosome function, but the primary function of 
CCR4 and CAF1 is in the deadenylation and degra- 
dation of cytoplasmic mRNA. As previous genetic 
analysis supported an interaction between SPT5, known 
to be involved in transcriptional elongation, and that 
of CCR4, the physical association of SPT5 with CCR4 
was examined. A two-hybrid screen utilizing the dea- 
denylase domain of CCR4 as a bait identified SPT5 as 
a potential interacting protein. SPT5 at its physio- 
logical concentration was shown to immunoprecipi- 
tate CCR4 and CAF1, and in vitro purified SPT5 spe- 
cifically could bind to CAF1 and the deadenylase do- 
main of CCR4. We additionally demonstrated that 
mutations in SPT5 or an spt4 deletion slowed the rate 
of mRNA degradation, a phenotype associated with 
defects in the CCR4 mRNA deadenylase complex. Yet, 
unlike ccr4 and caf1 deletions, spt5 and spt4 defects 
displayed little effect on the rate of deadenylation. They 
also did not affect decapping or 5' - 3' degradation of 
mRNA. These results suggest that the interactions be- 
tween SPT5/SPT4 and the CCR4-NOT complex are 
probably the consequences of effects involving nu- 
clear events and do not involve the primary role of 
CCR4 in mRNA deadenylation and turnover. 
 
Keywords: mRNA Degradation; CCR4-NOT Complex; 
SPT5/SPT4; Deadenylation 
1. INTRODUCTION 
The levels of eukaryotic mRNA can be regulated at many 
steps, from its initial synthesis to its eventual degradation 
in the cytoplasm. Regulation of the rate of mRNA decay 
is therefore an important control point in determining the 
abundance of cellular mRNA. A principal mRNA decay 
pathway in eukaryotic cells is initiated by shortening of 
the mRNA poly(A) tail at the 3′ end (deadenylation), 
followed by removal of the 5′ cap structure (decapping) 
and subsequent 5′ to 3′ exonuclease digestion [1-3]. Dea- 
denylation is a key rate-limiting step in the decay of 
mRNA in that it is the initial step for mRNA degradation. 
The rate of mRNA deadenylation also plays the most 
important role in affecting the overall mRNA turnover 
rate [4], and the poly(A) tail can stimulate the translation 
of mRNA [5]. Regulation of poly(A) tail length can 
therefore play multiple roles in controlling protein ex- 
pression.  
In yeast, the evolutionarily conserved CCR4 protein, 
as part of the CCR4-NOT complex, has been identified 
as the major cytoplasmic deadenylase [6-8]. Deletion of 
both CCR4 and PAN2, a poly(A) nuclease that processes 
the poly(A) tails of mRNA [9], completely blocks dea- 
denylation in vivo [8], indicating that these two deade- 
nylases comprise the vast majority of deadenylation fun- 
ction in yeast. Yet, the CCR4-NOT complex acts at seve- 
ral junctures in the formation of mRNA. Not only can the 
CCR4-NOT proteins, as the cytoplasmic deadenylase com- 
plex, act to control the degradation of mRNA [6-8,10,11], 
these factors also function in repressing the initiation of 
transcription through TFIID contacts [12,13], in tran- 
scriptional elongation [14,15], in aspects of transcription- 
coupled DNA repair [16], in regulating nuclear exosome 
function [17], in controlling mRNA export [18], and in 
the activation of transcription [19-22]. Consistent with 
their multiple functions, the CCR4-NOT proteins have 
been localized to both nuclear and cytoplasmic compart- 
ments [7,8]. 
The CCR4-NOT complex consists of two principal 
forms, 1.9 × 106 daltons (1.9 MDa) and 1.0 MDa in size 
[21,23]. The core 1.0 MDa complex has been purified 
and shown to consist of CCR4, CAF1, the five NOT pro-  
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teins (NOT1-5), CAF40, CAF130, and BTT1 [24,25]. 
The 1.9 MDa complex consists of this core and possibly 
several other proteins [21,26]. Within the 1.0 MDa com- 
plex the arrangement of factors has been delineated. 
NOT1 is the central protein in the complex [23,27]. 
CAF1 binds to the middle region of NOT1 and is abso- 
lutely required for linking CCR4 to the NOT1-5 proteins 
[21,23]. The NOT2, -4, and -5 proteins, in contrast, bind 
to the C-terminal region of NOT1. CAF130, BTT1, and 
CAF40 are located off of NOT1 in regions separate from 
CAF1/CCR4 and from NOT2/NOT4/NOT5 [24,25]. The 
multiple sizes of the CCR4-NOT complex, the numerous 
proteins present in it, and the distinct architecture of com- 
ponents within the 1.0 MDa complex are consistent with 
the complex, through its various interactions, playing 
multiple roles within the cell. 
Biochemical and bioinformatic studies have shown 
that CCR4 protein contains three major functional do- 
mains: an N-terminal activation domain that may interact 
with the transcriptional machinery, a central leucine-rich 
repeat (LRR) domain that binds CAF1 and several other 
putative components of the 1.9 MDa CCR4-NOT com- 
plex and is absolutely required for CCR4 enzyme func- 
tion, and a C-terminal exonuclease III like domain that 
comprises the CCR4 deadenylase function [6,7,26,28- 
30]. 
Previously, genetic analysis had indicated a functional 
connection between the CCR4-NOT complex and SPT5 
[14]. For example, a ccr4 deletion or overexpression of 
NOT1 suppressed the cold-sensitive phenotype of the 
spt5-242 allele [14]. SPT5 forms a complex with the 
SPT4 protein [31], called DSIF in mammalian cells [32]. 
SPT5/SPT4, like CCR4-NOT complex, is conserved 
throughout eukaryotes and has been found to be involved 
in multiple steps of mRNA processing. SPT5/SPT4 works 
in conjunction with both the positive transcription elon-
gation factor b (P-TEFb) and RNA pol II to control tran-
scriptional elongation [31,33,34]. SPT5/SPT4 has also 
been found to be involved in pre-mRNA processing and 
with the exosome [35,36]. These various functions indi-
cate a role for SPT5/SPT4 in pre-mRNA processing  
We report here that SPT5/SPT4 can co-immunopre- 
cipitate CCR4 and CAF1. Correspondingly, defects in 
SPT5 or SPT4 affected the rate of mRNA degradation. 
However, because these same defects did not display 
large effects on mRNA deadenylation, the SPT5/SPT4 
effects on mRNA degradation and interactions with the 
CCR4-NOT complex may not be directly related to the 
primary function of CCR4 in mRNA deadenylation. In- 
stead, these observations suggest that links between SPT5 
and CCR4 may result from other interactions that regu- 
late mRNA expression, processing, or transport in the 
nucleus. 
2. MATERIALS AND METHODS 
2.1. Yeast Strains and Growth Conditions 
Yeast strains are listed in Table 1. Growth conditions were 
on YEP medium (2% yeast extract/1% bactopeptone) 
supplemented with the appropriate carbon source as in-
dicated below. Two-hybrid assays were conducted in dip- 
loid strain EGY188/EGY191 containing the p34 plasmid 
(8 LexA operators upstream of lacZ) following growth on 
minimal medium [21] lacking uracil, tryptophan, and hi- 
stidine that was supplemented with 2% galactose/2% 
raffinose. Standard errors of the means for the assays 
were less than 20%. The plasmid pCAF1 is YEp13- 
CAF1-U whose LEU2 gene is now URA3. 
2.2. Immunoprecipitations, in Vitro Binding 
Asays, and Western Analysis  
Immunopreciptations with anti-Flag antibody were con-
ducted as previously described [21,37]. Western analysis 
utilized standard procedures [28]. GST fusion proteins 
were isolated from E. coli as described previously [38] 
and used to bind Flag purified SPT5-Flag isolated as 
described [6]. 
2.3. RNA Analysis 
Quantitative S1 nuclease protection assays were con-
ducted as described for determining mRNA degradation 
rates [39]. Control experiments in each case indicated 
that at the concentration of S1 nuclease used, no radioac- 
tively labeled oligonucleotide remained if no RNA was 
present and that the S1 nuclease assay was linear over 
the concentration of RNAs used. Total RNA were puri- 
fied as described previously [40,41]. Oligonucleotides 
were radiolabelled at their 5′ end with T4 polynucleotide 
kinase as described [6]. 
The deadenylation rates and deadenylation end points 
for GAL1 and MFA2pG mRNA were determined by us-
ing a transcriptional pulse-chase and RNase H assay as 
described previously [1,11,42-44]. For S1 analysis, the 
ADH2 probe contained the sequence +1126 to 1167 of 
ADH2 and the ACT1 probe contained the sequence +1039 
to +1098 of ACT1. For GAL1, a 3′ GAL1 probe was used 
for S1 analysis [42]. A phosphorimager was used to 
quantitate the relative densities of the ADH2 or GAL1 
mRNA levels as compared to the control ACT1. 
3. RESULTS 
3.1. SPT5 Can Interact Physically with CCR4 
Previously, we had conducted a two-hybrid screen for pro- 
teins interacting with the C-terminal deadenylase domain 
of CCR4 (residues 495-837) and had identified a small 
piece of SPT5 (residues 137-217) that could interact with  
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Table 1. Yeast strains. 
Strain Genotype 
EGY188 MATa ura3 his3 trp1 LexAop-LEU2 
EGY188-1a isogenic to EGY188 except ccr4::URA3 
EGY191 MAT ura3 his3 trp1 LexAop-LEU2 
FY1635 MAT his4-912 lys2-128 leu21 ura3-52 spt5-242 
FY300 MATa his4-912 lys2-128 leu21 ura3-52 spt5-194 
FY1668 MATa his4-912 lys2-128 spt5-4 
FY1642 MATa his4-912 lys2-128 leu21 ura3-52 SPT5-FLAG 
GHY180 MAT ura3-52 leu21 his 4-912 lys2-128 spt42::HIS3 
FY276 MATa leu21 ura3::TRP1 his4-9128 lys2-128 spt5-8
FY1635-1a isogenic to FY1635 except ccr4::URA3 
FY1668-1a isogenic to FY1668 except ccr4::URA3 and ura3::HIS3 
FY1642-1a isogenic to FY1642 except ccr4::URA3 
FY276-uT-1a isogenic to FY276 except ccr4::URA3 and ura3::TRP1 
FY1642-cl isogenic to FY1642 except caf1::LEU2 
L615 Mata his4-912 lys2-128 ura3-52 ade2-1 trp5 can1-100 spt5-25 
 
LexA-CCR4 (495-837) (31 U/mg -galactosidase acti- 
vity for LexA-CCR4 with B42-SPT5 (SPT5 fused to the 
E. coli transactivity domain B42) [21] as compared to 3.4 
U/mg of activity for LexA-CCR4 with B42 alone). To 
verify thatthe above described two-hybrid interaction 
was the result of an in vivo physical association, immu- 
noprecipitation analysis was conducted using full-length 
SPT5. The full length version of SPT5 when it was fused 
to B42 was capable of immunoprecipitating LexA-CCR4 
(495-837) (Figure 1, lane 6). These data indicate that the 
CCR4 exonuclease domain can contact SPT5. Other 
comparable LexAfusion proteins, such as LexA-MOB1 
or LexA-VpU were not immunoprecipitated by B42- 
SPT5 (Figure 1, lanes 4 and 5) and previous data has 
shown that CCR4 does not interact with the B42 domain 
alone [28].  
Because these above experiments were conducted with 
overexpressed versions of SPT5 and CCR4, we subse-
quently used the SPT5-Flag allele present at a single 
copy at its natural location in the genome to reconduct 
these immunoprecipitations [31]. Immunoprecipitating 
SPT5-Flag with anti-Flag antibody resulted in CCR4 
being co-immunoprecipitated (Figure 2, lane 7). The 
protein that was immunoprecipitated was identified as 
CCR4 as no protein co-immunoprecipitated from a strain 
deleted for CCR4 (lane 9). Also, a caf1 deletion elimi- 
nated the ability of CCR4 to co-immunoprecipitate with 
SPT5-Flag (lane 8), indicating that the CCR4 contact to 
at least the CAF1 component of the CCR4-NOT complex 
was required for CCR4 to be brought down with SPT5-  
 
Figure 1. SPT5 co-immunoprecipitates with CCR4- 
NOT components. Immunoprecipitations were con- 
ducted in diploid strain EGY188/EGY191 contain-
ing the B42 and LexA fusion proteins as indicated 
with the HA1 antibody that recognized the HA1 
epitope fused to the B42 transactivation domain. 
Western analysis utilized the anti-LexA antibody. 
Crude extracts-lanes 1 - 3; HA1 immunoprecipitate- 
slanes 4 - 6. B42-SPT5 contained full length SPT5; 
LexA fusions contained full length LexA (1 - 202) 
fused to complete versions of the indicated protein 
except for CCR4 (residues 495 - 837 were present). 
 
 
Figure 2. SPT5 immunoprecipitates CCR4 at their physiologi-
cal concentrations. Immunoprecipitations were conducted with 
anti-Flag antibody. Crude extracts: lanes 1 - 6; Flag immuno-
precipitates lanes 7 - 12. Anti-CCR4, -CAF1, and Flag anti-
bodies were used to identify CCR4, CAF1, and SPT5-Flag, 
respectively. Lanes 1 and 7: strain FY1642 (wt); lanes 2 and 8: 
strain FY1642-c1 (caf1); lanes 3 and 9: FY1642-1a (ccr4); 
lanes 4 and 10: strain FY1639 (no SPT5-Flag); lanes 5 and 11: 
strain FY1642 with pCAF1 (YEP13-CAF1-U); lanes 6 and 12: 
strain FY1639 with pCAF1. 
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Flag. As an additional control, Flag antibody did not co- 
immunoprecipitate CCR4 from a strain lacking SPT5- 
Flag (lane 10). These results confirm that CCR4 at its 
physiological concentration can associate with SPT5. 
Although no CAF1 protein appeared to co-immuno- 
precipitate with SPT5-Flag (Figure 2, lane 7), we were 
concerned that we might have missed observing 
CAF1 in the immunoprecipitate if the titer of the anti- 
CAF1 antibody were insufficient to detect the low levels 
of CAF1 that might be associated with SPT5. To ensure 
our ability to detect CAF1 we expressed CAF1 on a high 
copy plasmid under the control of its own promoter. The 
abundance of CAF1 protein made when CAF1 is ex- 
pressed from this high copy plasmid was about 3-to 
5-fold more than found in a wild-type CAF1 strain (Fig-
ure 2, compare lanes 1 to 5 or 4 to 6). When SPT5-Flag 
was immunoprecipitated with anti-Flag antibody from a 
strain carrying plasmid expressing CAF1, CAF1 was co- 
immunoprecipitated (Figure 2, lane 11). Although we 
observed some CAF1 being immunoprecipitated with 
Flag antibody from a strain lacking SPT5-Flag, the 
amount was reproducibly less than observed when SPT5- 
Flag was present (compare lanes 11 to 12, Figure 2). 
While the amount of CAF1 immunoprecipitating with 
SPT5 is low, these results indicate that CAF1, like CCR4, 
can associate with SPT5. It is worth nothing, however, 
that overexpression of CAF1 interfered with SPT5 co- 
immunoprecipitating CCR4. Since nearly all of the CCR4 
found in the cell is present in the CCR4-NOT complexes, 
the inability of SPT5 to apparently co-immunoprecipate 
other components of the complex along with CCR4 may 
imply that immunoprecipitating SPT5 helps separate 
CCR4 from the remainder of the complex or makes 
CCR4 less stably associated with other components of 
the complex.  
We also conducted the reverse experiment. When CCR4 
or CAF1 was immunoprecipitated, no SPT5-Flag protein 
was found to co-immunoprecipitate with the CCR4-NOT 
complex components (data not shown). This result is 
expected, however, as it has been previously established 
that immunoprecipitating the CCR4-NOT complex, when 
expressed at its physiological concentration, does not 
immunoprecipitate any proteins other than those which 
have been identified in the core 1.0 MDa CCR4-NOT 
complex [21,23,24]. 
3.2. SPT5 Does Not Associate in CCR4-NOT 
Complexes  
The above data indicates that SPT5 can physically inter- 
act with CCR4 and CAF1. SPT5 is unlikely, however, to 
be a component of the 1 MDa CCR4-NOT complex since 
neither SPT5 nor SPT4 were detected in the purified 1 
MDa complex [24]. It remained possible that SPT5 could 
be a component of the 1.9 MDa CCR4-NOT complex. To 
address this issue we analyzed the migration of SPT5 in 
crude extracts following Superose 6 gel chromatography. 
The majority of SPT5 was found to migrate at about 0.7 
MDa (Figure 3(a)), albeit a small amount was found to 
migrate at 1.9 MDa. We examined whether the SPT5 
migrating at 1.9 MDa was affected by deleting CCR4- 
NOT factors. SPT5 migration at 1.9 MDa was not af- 
fected by ccr4 (Figure 3(a), bottom panel), or other de- 
letions in CCR4-NOT components such as caf40, caf1, 
or not4 (data not shown), suggesting that SPT5 is not 
part of the 1.9 MDa CCR4-NOT complex. 
3.3. SPT5 Binds CCR4 and CAF1 in Vitro 
Our results indicate that SPT5 can interact with CCR4 
and CAF1 in vivo but it is unlikely to be tightly associ-
ated with the CCR4-NOT complex. We conducted in 
vitro binding assays to examine more thoroughly the 
SPT5 interaction with CCR4 and CAF1. These in vitro 
binding assays utilized SPT5-Flag that was expressed in 
yeast and GST-CAF1 and GST-CCR4 (495-837) isolated 
from E.coli (Figure 3(b), top panel). As shown in Figure 
3B, bottom panel, SPT5-Flag could be specifically re-
tained by GST-CAF1 and GST-CCR4 (lanes 3 and 5, 
respectively). GST alone or other comparable GST fu-
sions such as that of GST-CTD (C-terminal domain of 
RNA pol II) or GST-NOT2 were unable to retain SPT5- 
Flag (Figure 3(b), lanes 1, 2, and 5, respectively). 
3.4. spt5-4, spt5-194, and the spt4 Deletion Can 
Reduce the Rate of mRNA Degradation 
As the primary role for CCR4 is in the control of mRNA 
degradation, we subsequently examined the effect of 
several spt5 alleles and an spt4 deletion on the rate of 
mRNA decay. We observed that ADH2 mRNA was stabi-
lized approximately by a factor of 2-fold in spt5-194, 
spt5-4, and spt4 deletion strain backgrounds as compared 
to the wild type strain (Figure 4; Table 2). In the same 
strain background, a ccr4 deletion also resulted in a 
2-fold stabilization of ADH2 mRNA (Table 2), indicat-
ing that the magnitude of the spt5/4 effects was equiva-
lent to deleting ccr4 the major cyloplasmic deandenylase 
in yeast [8]. Combining ccr4 with spt5-4 did not further 
slow the rate of ADH2 mRNA degradation (Table 2). In 
contrast, in spt5-25, spt5-8, and spt5-242 strain back-
grounds, the rate of ADH2 mRNA decay was not affected 
(Figure 4, left panel; also Table 2). ccr4, however, in 
combination with spt5-242 or spt5-8 still decreased the 
rate of ADH2 mRNA degradation by 2-fold (Table 2). 
We also observed that spt5-4, like ccr4 and caf1 [8,43, 
44], slowed the rate of GAL1 mRNA degradation (spt5-4: 
20 min T1/2 compared to wild type: 12 min T1/2). These 
results indicate that certain alleles of spt5 or deletion of 
spt4 result in slowing the rate of mRNA decay. Since the 
Copyright © 2012 SciRes.                                                                       OPEN ACCESS 





Figure 3. (a) Deletion of CCR4 does not affect SPT5 migra- 
tion in a 1.9 MDa complex. Superose 6 gel chromatography 
was conducted on crude extracts as previously described [23]. 
Anti-Flag antibody was utilized to detect SPT5-Flag by West- 
ern analysis. WT-strain FY1642; ccr4-strain FY1642-1a. Mo- 
lecular weight markers were Blue dextran –2 MDa; Thyro- 
globulin –0.67 MDa; and bovine serum albumin –0.06 MDa. (b) 
CCR4 and CAF1 can bind SPT5 in vitro. Purified GST-CCR4 
(495-837) and GST-CAF1 (top panel) were used to bind ex-
tracts containing Flag purified SPT5-Flag (top panel). GST- 
pull down experiments were conducted as previously described 
(38). Top panel—Coomassie stained profiles of GST and Flag 
fusion proteins; bottom panel—Western analysis of SPT5-Flag 
retention on glutathine agarose columns containing GST fusion 
proteins as indicated. All GST fusions contained full-length 
proteins except for CCR4 (495-837). GST-CTD refers to the C- 
terminal domain of RNA pol II (52). Input SPT5-Flag repre-
sents one-twenty fifth of the amount used to bind the GST fu-
sion proteins. About 12% of the SPT5-Flag was retained by 
GST-CAF1 and 2% was retained by GST-CCR4. 
 
spt5-4 and spt5-194 alleles, in contrast to the spt5-242 
allele, have been implicated in disrupting SPT5-SPT4 
interactions (G. Hartzog, pers. comm.), the integrity of 
the SPT5-SPT4 contact may be important to mRNA de- 
gradation. 
3.5. spt5 and spt4 Mutations Do Not Affect 
mRNA Decapping or Deadenylation  
The role of SPT5/SPT4 on mRNA degradation could be 
occurring by effects on the deadenylation, decapping or 
5′ to 3′ degradation of the RNA transcript [45]. A simple 
test to determine whether defects in mRNA decay occur 
at the decapping or later step is to analyze the degrada-
tion products of the MFA2pG RNA relative to the total  
 
Figure 4. spt5 and spt4 alleles affect ADH2 mRNA degradation 
rates. Wild-type and mutant strains (see Table 1) were pre- 
grown on YEP medium containing 2% ethanol/2% glycerol 
prior to shifting to medium containing 4% glucose at zero time 
and the taking of RNA samples at the times indicated. The 
ADH2 and ACT1 mRNA levels were determined by S1 nucle-
ase protection assays. The ACT1 RNA was used to standardize 
loadings for RNA samples at the different time points indicated. 
T1/2 values are for the data shown. 
 
Table 2. Effect of spt5/spt4 alleles on ADH2 mRNA degrada-
tion rates. 









spt5-4 ccr4 25 
spt5-8 ccr4 31 
spt5-242 ccr4 25 
ADH2 mRNA half-lives were determined following pre-growth of yeast on 
YEP medium supplemented with 4% glucose, shifting to medium containing 
2% ethanol/2%glycerol for 3 hr, and repression of ADH2 mRNA synthesis 
at time zero by the switching to fresh medium containing 8% glucose [6]. 
RNA half lives were determined using ACT1 as a standard as described [6]. 
Values are the average of three to eight determinations.  Standard errors of 
the mean (SEM) were less than 15% except for spt5-194 whose SEM was 
25%. spt5-242 data represents a single determination. 
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level of MFA2pG RNA present [46]. The MFA2pG gene 
contains a poly(G) tract insertion in its 3′ UTR that in-
hibits exonuclease activity [1]. Therefore, a poly(G) to 3′ 
end RNA fragment will accumulate when the decapped 
mRNA is degraded from the 5′ to 3′ direction. However, 
in the absence of any decapping and 5′ to 3′ mRNA di-
gestion, the formation of the poly(G) 3′ end RNA frag-
ment will be blocked. As shown in Figure 5, spt5-4 had 
no obvious effect on the abundance of the poly(G) 
mRNA fragment relative to the full-length MFA2pG 
mRNA (Figure 5, lane 2 compared to lane 1). Careful 
analysis of the data indicated that spt5-4 resulted in the 
poly(G) fragment to be slightly longer than wild-type 
indicative of a very short poly(A) tail remaining on the 
poly(G) fragment. Over the course of several experi-
ments, it appears that the oligo poly(A) tail remaining in 
an spt5-4 background is about 1-3 nucleotides longer in 
length as compared to that found in wild-type. Similar 
results were obtained with spt5-194 and spt4 (data not 
shown). In comparison, ccr4 also does not block decap-
ping or 5' to 3' mRNA degradation (Figure 5, lane 3) and 
leaves a terminal 20 - 25 poly(A) tail on the fragment [8]. 
These results indicate that the spt5/spt4 alleles are not 
affecting decapping or subsequent 5′ RNA degradation. 
We subsequently tested whether these alleles affected 
the rate of mRNA deadenylation, the same step that 
CCR4 and CAF1 control. Changes in the mRNA deade- 
nylation rate were followed using a transcriptional pulse 
chase analysis [1] with the GAL1 mRNA. Expression of 
GAL1 was rapidly induced for 15 minutes by adding ga-
lactose to a raffinose growth culture and then repressed 
by adding glucose. The deadenylation of this pool of 
newly synthesized GAL1 mRNA was monitored at dif-
ferent time points by Northern analysis. GAL1 mRNA 
contains two polyadenylation sites [43,44,47] and the 
RNA corresponding to the shorter RNA is displayed in 
Figure 6. Similar results were obtained with the longer 
RNA (data not shown). 
As shown in Figure 6, we observed that, in a wild- 
type strain, by following the shortest poly(A) tail frag- 
ments present at a particular time [1], the poly (A) tail 
was degraded to an oligo(A) tail length of approximately 
8 - 13 A’s by around 10 minutes minutes, and by 15 mi- 
nutes a significant portion of the mRNA were in the 
oligo(A) form. It has been shown previously that decap-
ping and 5′ to 3′ degradation of the transcript occurs once 
the oligo(A) tail form (8 - 13 A’s) appears [1,2,48]. Simi-
larly in the spt5-242 strain, which had no effect on ADH2 
or GAL1 mRNA decay rate, the oligo(A) tail was formed 
in 10 to 15 minutes (Figure 6, left panel). In the spt5-4 
and spt4 deletion strains, the oligo(A) tail form of GAL1 
mRNA routinely appeared in 15 minutes and some was 
visible at ten minutes (Figure 6, right panel). The spt5-4 
and spt4 alleles had similar effects on the deadenylation 
of the long GAL1 mRNA (data not shown). ccr4 effects 
 
Figure 5. spt5 and spt4 alleles do not affect mRNA degradative 
steps after deadenylation. Wild-type (FY1642), spt5-4 (FY1668- 
uH), and ccr4 (FY1642-1a) strains containing plasmid RP485 
(MFA2pG) [1] were grown in CAA-U- medium [21] with 4% 
glucose to mid-log stage. Total RNA were extracted after shift-
ing to 2% galactose for 4 hours. MFA2pG transcripts were de-
tected following Northern analysis [8]. The upper band repre-
sents the full-length MFA2pG transcript and the lower band 
corresponds to the poly(G) to 3′ end RNA fragment. The fully 
deadenylated MFA2pG RNAs were identified by RNase H 
treatment after hybridization to oligo d(T) (not shown) [8]. 
 
 
Figure 6. The effect of spt5/spt4 alleles on the rate of GAL1 
mRNA deadenylation. Wild-type (FY1642), spt5-4 (FY1668- 
uH), spt5-242 (FY1635), and spt4 (GHY180) strains was 
shifted from raffinose-containing YEP medium to galactose- 
containing YEP medium for 15 minutes to induce GAL1 gene 
expression. After transcriptional repression by the addition of 
glucose, total RNA were extracted at different time points as 
indicated. GAL1 mRNA was detected by Northern analysis 
following RNase H treatment of the RNA after hybridization to 
a 3′ GAL1 RNA probe (Materials and Methods) [42]. The 
GAL1 mRNA shown is the short GAL1 RNA which is 110 nt 
shorter at its 3′ end than the long GAL1 mRNA [47]. dT-RNase 
treatment of the RNA following hybridization to oligo d(T) to 
identify the fully deadenylated species. 
 
on the rate of GAL1 deadenylation, however, have been 
shown to be much more severe in which the oligo (A) 
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did not appear until after at least 40 minutes [8,43,44]. 
These observations indicate that the deadenylation rate of 
GAL1 mRNA is not significantly reduced by the spt5-4 
and spt4 defects, although they do slow the rate of 
mRNA degradation to an extent comparable to that ob- 
served for ccr4. It should be noted that we also examined 
the ability of the spt5-4 and spt4 defect on the ability of 
SPT5-Flag to associate with CCR4. However, neither of 
these defects had any effect on the ability of CCR4 to 
associate with SPT5 (data not shown), suggesting that 
the effect of these alleles on mRNA degradation was not 
simply due to their inability to bind CCR4. 
4. DISCUSSION 
4.1. SPT5 Interacts Physically with CCR4 and 
CAF1 
The SPT5 protein was shown to physically associate in 
vivo and in vitro with CCR4 and CAF1. Initially, a por- 
tion of the SPT5 protein was identified as interacting 
with the exonuclease domain of CCR4 using a two-hy- 
brid screen, a result verified by co-immunoprecipitation 
analysis. We subsequently showed that full-length SPT5 
could immunoprecipitate full-length CCR4 when both 
were expressed at their physiological concentrations. 
CAF1 could also immunoprecipitate with SPT5, although 
CAF1 needed to be slightly overexpressed for this effect 
to be observed. In addition, overexpression of CAF1 
interfered with CCR4 interaction with SPT5. These re- 
sults indicate a close proximity in the cell of CCR4 and 
CAF1 with SPT5. However, the interaction of CCR4 and 
CAF1 with SPT5 may not be very tight. The fact that 
other CCR4-NOT components at their physiological con- 
centrations were not co-immunoprecipitated with SPT5 
suggests that the CCR4-SPT5 interaction is not bringing 
along the whole complex. 
Several pieces of evidence indicate that SPT5 is not in 
the most common complexes associated with CCR4 and 
CAF1. The purified 1.0 MDa CCR4-NOT complex does 
not contain SPT5 or SPT4 [24]. Also, immunoprecipitat- 
ing any of the 1.0 MDa CCR4-NOT protein components 
does not co-immunoprecipitate any other proteins (data 
not shown) [49]. SPT5 was shown to migrate in com-
plexes sized at both 1.9 and 0.7 MDa, although the bulk 
of the SPT5 protein is in the smaller complex. Deleting 
CCR4, CAF1, CAF40 or NOT4 was found to have no 
effect on SPT5 migration in either of these complexes. 
Deleting CAF1 has previously been shown to reduce 
CCR4 presence in the 1.9 MDa CCR4-NOT complex [21] 
and deleting CCR4 eliminates the association of CAF16 
with the 1.9 MDa complex [26]. It is, therefore, unlikely 
that SPT5 is part of the 1.9 MDa CCR4-NOT complex 
unless it were retaining its association in this complex 
through other as yet undetermined protein interactions. 
We conclude, therefore, that the interaction between 
SPT5 and that of CCR4 and CAF1 is of a weaker and/or 
more transient nature than the interactions observed for 
components within the CCR4-NOT complex. 
4.2. SPT5 Plays a Role in the Control of mRNA 
Degradation But Not That of Deadenylation 
The SPT5 protein has been ascribed several roles in 
mRNA metabolism including that of affecting transcrip- 
tional initiation, mRNA elongation, and possibly splicing 
and capping [31,35,50]. Based on our previous data sup-
porting a genetic interaction between SPT5 and CCR4 and 
the current data supporting their physical interaction, we 
have examined the role of SPT5/SPT4 in mRNA degra-
dation. Defects in both SPT5 and SPT4 were found to 
reduce the rate of degradation of mRNA. The magni- 
tude of this effect on the rate of ADH2 mRNA degrada- 
tion was equivalent to the effect of deleting CCR4, the 
major cytoplasmic deadenylase in yeast [8]. However, 
SPT5 or SPT4 defects that affected the degradation rate 
did not appreciably affect the rate of deadenylation. Also, 
SPT5 defects did not result in a dramatic deadenylation 
end-point defect, as has been observed with either ccr4 
or caf1 [8]. As observed in the deadenylation of MFA2pG, 
spt5-4 resulted in a deadenylation end-point with 1 - 3 
A’s remaining in contrast to the 20 - 25 A’s remaining 
typically observed in a ccr4 strain. Similarly, in the 
deadenylation of GAL1 mRNA, SPT5 or SPT4 defects 
resulted in the complete or nearly complete deadenyla-
tion of the RNA (Figure 6) whereas ccr4 and caf1 de-
fects result in the accumulation of only partially deade-
nylated species [8,11,43,44]. Moreover, defects in either 
SPT5 or SPT4 had no apparent effects on decapping or 5′ 
exonuclease activity. These data indicate that SPT5/SPT4 
are involved in affecting mRNA degradation, but do so 
by a mechanism that is not clearly related to effects on 
CCR4 or on cytoplasmic mRNA degradation. 
SPT5 hence may associate with CCR4 in the nucleus 
and affect any number of transcriptional or post-tran- 
scriptional roles assigned to these factors. It is also pos- 
sible, given the variety of roles ascribed to SPT5, that its 
effects on mRNA degradation are indirect. A key con- 
clusion from these studies is that analysis of mRNA deg-
radation rates alone is insufficient to determine whether 
particular factors are actually involved in the cytoplasmic 
control of mRNA turnover. 
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